Johnson & Johnson Ordered to Pay $572 Million in Landmark Opioid Trial
- 5 years ago
Johnson & Johnson
Ordered to Pay $572 Million
in Landmark Opioid Trial.
An Oklahoma judge ordered
the corporate giant to pay
the massive sum to the state.
The judgement was made
in response to the opioid epidemic,
"an imminent danger and
menace to Oklahomans.".
Through contracts with poppy
growers in Tasmania, Johnson & Johnson
has supplied 60% of the ingredients
used for opioids such as oxycodone.
The state argued that the
company marketed the products
as safe to both patients and doctors.
We’ve shown that J&J was at the root cause of this opioid crisis. It made billions of dollars from it over a 20-year period. They’ve always denied responsibility and yet at the same time they say they want to make a difference in solving this problem. So do the right thing: come in here, pay the judgment, Brad Beckworth, Oklahoma State Attorney,
via 'The New YorkTimes'.
The ruling is the first of its kind,
in which a corporation has been
deemed responsible for
America's opioid crisis.
Around two dozen opioid retailers,
makers and distributors face
judgement in more than 2,000
related lawsuits, all over the U.S.
Ordered to Pay $572 Million
in Landmark Opioid Trial.
An Oklahoma judge ordered
the corporate giant to pay
the massive sum to the state.
The judgement was made
in response to the opioid epidemic,
"an imminent danger and
menace to Oklahomans.".
Through contracts with poppy
growers in Tasmania, Johnson & Johnson
has supplied 60% of the ingredients
used for opioids such as oxycodone.
The state argued that the
company marketed the products
as safe to both patients and doctors.
We’ve shown that J&J was at the root cause of this opioid crisis. It made billions of dollars from it over a 20-year period. They’ve always denied responsibility and yet at the same time they say they want to make a difference in solving this problem. So do the right thing: come in here, pay the judgment, Brad Beckworth, Oklahoma State Attorney,
via 'The New YorkTimes'.
The ruling is the first of its kind,
in which a corporation has been
deemed responsible for
America's opioid crisis.
Around two dozen opioid retailers,
makers and distributors face
judgement in more than 2,000
related lawsuits, all over the U.S.